-
1
-
-
0031849153
-
Ribonucleotide reductases and radical reactions
-
Fontecave M. Ribonucleotide reductases and radical reactions. Cell Mol Life Sci. 1998;54(7):684-95.
-
(1998)
Cell Mol Life Sci
, vol.54
, Issue.7
, pp. 684-695
-
-
Fontecave, M.1
-
2
-
-
0020541188
-
Ribonucleotide reductase - A radical enzyme
-
New York, NY
-
Reichard P, Ehrenberg A. Ribonucleotide reductase - a radical enzyme. Science (New York, NY). 1983;221(4610):514-9.
-
(1983)
Science
, vol.221
, Issue.4610
, pp. 514-519
-
-
Reichard, P.1
Ehrenberg, A.2
-
4
-
-
2542504483
-
Structure, function, and mechanism of ribonucleotide reductases
-
Kolberg M, Strand KR, Graff P, Andersson KK. Structure, function, and mechanism of ribonucleotide reductases. Biochim Biophys Acta. 2004;1699(1-2):1-34.
-
(2004)
Biochim Biophys Acta
, vol.1699
, Issue.1-2
, pp. 1-34
-
-
Kolberg, M.1
Strand, K.R.2
Graff, P.3
Andersson, K.K.4
-
5
-
-
0029946035
-
Ribonucleotide reductase inhibitors: New strategies for cancer chemotherapy
-
Nocentini G. Ribonucleotide reductase inhibitors: new strategies for cancer chemotherapy. Crit Rev Oncol Hematol. 1996;22(2):89-126.
-
(1996)
Crit Rev Oncol Hematol
, vol.22
, Issue.2
, pp. 89-126
-
-
Nocentini, G.1
-
6
-
-
0024236511
-
Ribonucleotide reductase as a chemotherapeutic target
-
Cory JG. Ribonucleotide reductase as a chemotherapeutic target. Adv Enzyme Regul. 1988;27:437-55.
-
(1988)
Adv Enzyme Regul
, vol.27
, pp. 437-455
-
-
Cory, J.G.1
-
7
-
-
0038615898
-
GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumors
-
Lee Y, Vassilakos A, Feng N, Lam V, Xie H, Wang M, et al. GTI-2040, an antisense agent targeting the small subunit component (R2) of human ribonucleotide reductase, shows potent antitumor activity against a variety of tumors. Cancer Res. 2003;63(11):2802-11.
-
(2003)
Cancer Res
, vol.63
, Issue.11
, pp. 2802-2811
-
-
Lee, Y.1
Vassilakos, A.2
Feng, N.3
Lam, V.4
Xie, H.5
Wang, M.6
-
8
-
-
0042062334
-
Ribonucleotide reductase: An old target with new potential
-
Smith BD, Karp JE. Ribonucleotide reductase: an old target with new potential. Leuk Res. 2003;27(12):1075-6.
-
(2003)
Leuk Res
, vol.27
, Issue.12
, pp. 1075-1076
-
-
Smith, B.D.1
Karp, J.E.2
-
9
-
-
0028070503
-
Inhibition of ribonucleotide reductase by 2′-substituted deoxycytidine analogs: Possible application in AIDS treatment
-
Bianchi V, Borella S, Calderazzo F, Ferraro P, Chieco Bianchi L, Reichard P. Inhibition of ribonucleotide reductase by 2′-substituted deoxycytidine analogs: possible application in AIDS treatment. Proc Natl Acad Sci USA. 1994;91(18):8403-7.
-
(1994)
Proc Natl Acad Sci USA
, vol.91
, Issue.18
, pp. 8403-8407
-
-
Bianchi, V.1
Borella, S.2
Calderazzo, F.3
Ferraro, P.4
Chieco Bianchi, L.5
Reichard, P.6
-
10
-
-
21344458583
-
A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors
-
Desai AA, Schilsky RL, Young A, Janisch L, Stadler WM, Vogelzang NJ, et al. A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors. Ann Oncol. 2005;16(6):958-65.
-
(2005)
Ann Oncol
, vol.16
, Issue.6
, pp. 958-965
-
-
Desai, A.A.1
Schilsky, R.L.2
Young, A.3
Janisch, L.4
Stadler, W.M.5
Vogelzang, N.J.6
-
11
-
-
0035446823
-
Therapeutic options for acute myelogenous leukemia
-
Estey EH. Therapeutic options for acute myelogenous leukemia. Cancer. 2001;92(5):1059-73.
-
(2001)
Cancer
, vol.92
, Issue.5
, pp. 1059-1073
-
-
Estey, E.H.1
-
12
-
-
0037246483
-
Recent advances in pediatric acute lymphoblastic and myeloid leukemia
-
Ravindranath Y. Recent advances in pediatric acute lymphoblastic and myeloid leukemia. Curr Opin Oncol. 2003;15(1):23-35.
-
(2003)
Curr Opin Oncol
, vol.15
, Issue.1
, pp. 23-35
-
-
Ravindranath, Y.1
-
13
-
-
0013955532
-
Biochemical and pharmacological studies with 1-beta-D- arabinofuranosylcytosine in man
-
Creasey WA, Papac RJ, Markiw ME, Calabresi P, Welch AD. Biochemical and pharmacological studies with 1-beta-D-arabinofuranosylcytosine in man. Biochem Pharmacol. 1966;15(10):1417-28.
-
(1966)
Biochem Pharmacol
, vol.15
, Issue.10
, pp. 1417-1428
-
-
Creasey, W.A.1
Papac, R.J.2
Markiw, M.E.3
Calabresi, P.4
Welch, A.D.5
-
14
-
-
52449105507
-
Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemia
-
Klisovic RB, Blum W, Wei X, Liu S, Liu Z, Xie Z, et al. Phase I study of GTI-2040, an antisense to ribonucleotide reductase, in combination with high-dose cytarabine in patients with acute myeloid leukemia. Clin Cancer Res. 2008;14(12):3889-95.
-
(2008)
Clin Cancer Res
, vol.14
, Issue.12
, pp. 3889-3895
-
-
Klisovic, R.B.1
Blum, W.2
Wei, X.3
Liu, S.4
Liu, Z.5
Xie, Z.6
-
16
-
-
33745329502
-
A specific picomolar hybridization-based ELISA assay for the determination of phosphorothioate oligonucleotides in plasma and cellular matrices
-
Wei X, Dai G, Marcucci G, Liu Z, Hoyt D, Blum W, et al. A specific picomolar hybridization-based ELISA assay for the determination of phosphorothioate oligonucleotides in plasma and cellular matrices. Pharm Res. 2006;23(6):1251-64.
-
(2006)
Pharm Res
, vol.23
, Issue.6
, pp. 1251-1264
-
-
Wei, X.1
Dai, G.2
Marcucci, G.3
Liu, Z.4
Hoyt, D.5
Blum, W.6
-
17
-
-
67349234105
-
A LC-MS/MS method for the analysis of intracellular nucleoside triphosphate levels
-
Chen P, Liu Z, Liu S, Xie Z, Aimiuwu J, Pang J, et al. A LC-MS/MS method for the analysis of intracellular nucleoside triphosphate levels. Pharm Res. 2009;26(6):1504-15.
-
(2009)
Pharm Res
, vol.26
, Issue.6
, pp. 1504-1515
-
-
Chen, P.1
Liu, Z.2
Liu, S.3
Xie, Z.4
Aimiuwu, J.5
Pang, J.6
-
18
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: The combined effects of multiple drugs or enzyme inhibitors
-
Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul. 1984;22:27-55.
-
(1984)
Adv Enzyme Regul
, vol.22
, pp. 27-55
-
-
Chou, T.C.1
Talalay, P.2
-
19
-
-
0023589415
-
Biochemical pharmacology of high dose 1-beta-D-arabinofuranosylcytosine in childhood acute leukemia
-
Avramis VI, Biener R, Krailo M, Finklestein J, Ettinger L, Willoughby M, et al. Biochemical pharmacology of high dose 1-beta-D-arabinofuranosylcytosine in childhood acute leukemia. Cancer Res. 1987;47(24 Pt 1):6786-92.
-
(1987)
Cancer Res
, vol.47
, Issue.24 PART 1
, pp. 6786-6792
-
-
Avramis, V.I.1
Biener, R.2
Krailo, M.3
Finklestein, J.4
Ettinger, L.5
Willoughby, M.6
-
20
-
-
0034087978
-
Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: No effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine
-
Braess J, Wegendt C, Jahns-Streubel G, Kern W, Keye S, Unterhalt M, et al. Successful modulation of high-dose cytosine arabinoside metabolism in acute myeloid leukaemia by haematopoietic growth factors: no effect of ribonucleotide reductase inhibitors fludarabine and gemcitabine. Br J Haematol. 2000;109(2):388-95.
-
(2000)
Br J Haematol
, vol.109
, Issue.2
, pp. 388-395
-
-
Braess, J.1
Wegendt, C.2
Jahns-Streubel, G.3
Kern, W.4
Keye, S.5
Unterhalt, M.6
-
21
-
-
0022366259
-
Relationship of 1-beta-D-arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5′-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine
-
Liliemark JO, Plunkett W, Dixon DO. Relationship of 1-beta-D- arabinofuranosylcytosine in plasma to 1-beta-D-arabinofuranosylcytosine 5′-triphosphate levels in leukemic cells during treatment with high-dose 1-beta-D-arabinofuranosylcytosine. Cancer Res. 1985;45(11 Pt 2):5952-7.
-
(1985)
Cancer Res
, vol.45
, Issue.11 PART 2
, pp. 5952-5957
-
-
Liliemark, J.O.1
Plunkett, W.2
Dixon, D.O.3
-
22
-
-
11144358126
-
The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients
-
Ossenkoppele GJ, Graveland WJ, Sonneveld P, Daenen SM, Biesma DH, Verdonck LF, et al. The value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high-risk myelodysplastic syndromes and AML in elderly patients. Blood. 2004;103(8):2908-13.
-
(2004)
Blood
, vol.103
, Issue.8
, pp. 2908-2913
-
-
Ossenkoppele, G.J.1
Graveland, W.J.2
Sonneveld, P.3
Daenen, S.M.4
Biesma, D.H.5
Verdonck, L.F.6
-
23
-
-
0031789029
-
Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemia
-
Ozkaynak MF, Avramis VI, Carcich S, Ortega JA. Pharmacology of cytarabine given as a continuous infusion followed by mitoxantrone with and without amsacrine/etoposide as reinduction chemotherapy for relapsed or refractory pediatric acute myeloid leukemia. Med Pediatr Oncol. 1998;31(6):475-82.
-
(1998)
Med Pediatr Oncol
, vol.31
, Issue.6
, pp. 475-482
-
-
Ozkaynak, M.F.1
Avramis, V.I.2
Carcich, S.3
Ortega, J.A.4
-
24
-
-
0019963710
-
Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C)
-
Breithaupt H, Pralle H, Eckhardt T, von Hattingberg M, Schick J, Loffler H. Clinical results and pharmacokinetics of high-dose cytosine arabinoside (HD ARA-C). Cancer. 1982;50(7):1248-57.
-
(1982)
Cancer
, vol.50
, Issue.7
, pp. 1248-1257
-
-
Breithaupt, H.1
Pralle, H.2
Eckhardt, T.3
Von Hattingberg, M.4
Schick, J.5
Loffler, H.6
-
25
-
-
0021341818
-
Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase
-
Capizzi RL, Poole M, Cooper MR, Richards 2nd F, Stuart JJ, Jackson Jr DV, et al. Treatment of poor risk acute leukemia with sequential high-dose ARA-C and asparaginase. Blood. 1984;63(3):694-700.
-
(1984)
Blood
, vol.63
, Issue.3
, pp. 694-700
-
-
Capizzi, R.L.1
Poole, M.2
Cooper, M.R.3
Richards II, F.4
Stuart, J.J.5
Jackson Jr., D.V.6
-
26
-
-
0025737279
-
Effect of dose on the pharmacokinetic and pharmacodynamic effects of cytarabine
-
Capizzi RL, White JC, Powell BL, Perrino F. Effect of dose on the pharmacokinetic and pharmacodynamic effects of cytarabine. Semin Hematol. 1991;28(3 Suppl 4):54-69.
-
(1991)
Semin Hematol
, vol.28
, Issue.3 SUPPL. 4
, pp. 54-69
-
-
Capizzi, R.L.1
White, J.C.2
Powell, B.L.3
Perrino, F.4
-
27
-
-
0023470734
-
Variables predicting response to high dose cytosine arabinoside therapy in patients with refractory acute leukemia
-
Estey E, Plunkett W, Dixon D, Keating M, McCredie K, Freireich EJ. Variables predicting response to high dose cytosine arabinoside therapy in patients with refractory acute leukemia. Leukemia. 1987;1(8):580-3.
-
(1987)
Leukemia
, vol.1
, Issue.8
, pp. 580-583
-
-
Estey, E.1
Plunkett, W.2
Dixon, D.3
Keating, M.4
McCredie, K.5
Freireich, E.J.6
-
28
-
-
34547702377
-
Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia
-
Qian SX, Li JY, Tian T, Shen YF, Jiang YQ, Lu H, et al. Effect of low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor priming (CAG regimen) on the outcome of elderly patients with acute myeloid leukemia. Leuk Res. 2007;31(10):1383-8.
-
(2007)
Leuk Res
, vol.31
, Issue.10
, pp. 1383-1388
-
-
Qian, S.X.1
Li, J.Y.2
Tian, T.3
Shen, Y.F.4
Jiang, Y.Q.5
Lu, H.6
-
29
-
-
0019948735
-
High dose cytosine arabinoside in the management of refractory acute leukaemia
-
Willemze R, Zwaan FE, Colpin G, Keuning JJ. High dose cytosine arabinoside in the management of refractory acute leukaemia. Scand J Haematol. 1982;29(2):141-6.
-
(1982)
Scand J Haematol
, vol.29
, Issue.2
, pp. 141-146
-
-
Willemze, R.1
Zwaan, F.E.2
Colpin, G.3
Keuning, J.J.4
-
30
-
-
34547794827
-
Combined low-dose cytarabine, melphalan and mitoxantrone for older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome
-
Yamauchi T, Negoro E, Arai H, Ikegaya S, Takagi K, Takemura H, et al. Combined low-dose cytarabine, melphalan and mitoxantrone for older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome. Anticancer Res. 2007;27(4C):2635-9.
-
(2007)
Anticancer Res
, vol.27
, Issue.4 C
, pp. 2635-2639
-
-
Yamauchi, T.1
Negoro, E.2
Arai, H.3
Ikegaya, S.4
Takagi, K.5
Takemura, H.6
-
31
-
-
39749118640
-
Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia
-
Zhang WG, Wang FX, Chen YX, Cao XM, He AL, Liu J, et al. Combination chemotherapy with low-dose cytarabine, homoharringtonine, and granulocyte colony-stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia. Am J Hematol. 2008;83(3):185-8.
-
(2008)
Am J Hematol
, vol.83
, Issue.3
, pp. 185-188
-
-
Zhang, W.G.1
Wang, F.X.2
Chen, Y.X.3
Cao, X.M.4
He, A.L.5
Liu, J.6
-
32
-
-
10344238081
-
Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells
-
Bauer W, Horvath Z, Hochtl T, Saiko P, Karl D, Fritzer-Szekeres M, et al. Amidox, an inhibitor of ribonucleotide reductase, potentiates the action of Ara-C in HL-60 human promyelocytic leukemia cells. Nucleosides Nucleotides Nucleic Acids. 2004;23(8-9):1541-4.
-
(2004)
Nucleosides Nucleotides Nucleic Acids
, vol.23
, Issue.8-9
, pp. 1541-1544
-
-
Bauer, W.1
Horvath, Z.2
Hochtl, T.3
Saiko, P.4
Karl, D.5
Fritzer-Szekeres, M.6
-
33
-
-
0036683718
-
Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells
-
Fritzer-Szekeres M, Salamon A, Grusch M, Horvath Z, Hochtl T, Steinbrugger R, et al. Trimidox, an inhibitor of ribonucleotide reductase, synergistically enhances the inhibition of colony formation by Ara-C in HL-60 human promyelocytic leukemia cells. Biochem Pharmacol. 2002;64(3):481-5.
-
(2002)
Biochem Pharmacol
, vol.64
, Issue.3
, pp. 481-485
-
-
Fritzer-Szekeres, M.1
Salamon, A.2
Grusch, M.3
Horvath, Z.4
Hochtl, T.5
Steinbrugger, R.6
-
34
-
-
0018104806
-
Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin
-
Plagemann PG, Behrens M, Abraham D. Metabolism and cytotoxicity of 5-azacytidine in cultured Novikoff rat hepatoma and P388 mouse leukemia cells and their enhancement by preincubation with pyrazofurin. Cancer Res. 1978;38(8):2458-66.
-
(1978)
Cancer Res
, vol.38
, Issue.8
, pp. 2458-2466
-
-
Plagemann, P.G.1
Behrens, M.2
Abraham, D.3
-
35
-
-
0030042611
-
Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: Pharmacokinetic, pharmacodynamic, and molecular interactions
-
Gandhi V, Estey E, Keating MJ, Chucrallah A, Plunkett W. Chlorodeoxyadenosine and arabinosylcytosine in patients with acute myelogenous leukemia: pharmacokinetic, pharmacodynamic, and molecular interactions. Blood. 1996;87(1):256-64.
-
(1996)
Blood
, vol.87
, Issue.1
, pp. 256-264
-
-
Gandhi, V.1
Estey, E.2
Keating, M.J.3
Chucrallah, A.4
Plunkett, W.5
-
36
-
-
0029077399
-
Modulation of arabinosylcytosine metabolism during leukemia therapy
-
Gandhi V, Estey E, Plunkett W. Modulation of arabinosylcytosine metabolism during leukemia therapy. Adv Exp Med Biol. 1994;370:119-24.
-
(1994)
Adv Exp Med Biol
, vol.370
, pp. 119-124
-
-
Gandhi, V.1
Estey, E.2
Plunkett, W.3
-
37
-
-
0024436221
-
Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: Implications for combination therapy
-
Gandhi V, Nowak B, Keating MJ, Plunkett W. Modulation of arabinosylcytosine metabolism by arabinosyl-2-fluoroadenine in lymphocytes from patients with chronic lymphocytic leukemia: implications for combination therapy. Blood. 1989;74(6):2070-5.
-
(1989)
Blood
, vol.74
, Issue.6
, pp. 2070-2075
-
-
Gandhi, V.1
Nowak, B.2
Keating, M.J.3
Plunkett, W.4
-
38
-
-
0025718578
-
Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells
-
Bhalla K, Swerdlow P, Grant S. Effects of thymidine and hydroxyurea on the metabolism and cytotoxicity of 1-B-D arabinofuranosylcytosine in highly resistant human leukemia cells. Blood. 1991;78(11):2937-44.
-
(1991)
Blood
, vol.78
, Issue.11
, pp. 2937-2944
-
-
Bhalla, K.1
Swerdlow, P.2
Grant, S.3
-
39
-
-
0026755674
-
Increase in Ara-C sensitivity in Ara-C sensitive and -resistant leukemia by stimulation of the salvage and inhibition of the de novo pathway
-
Colly LP, Richel DJ, Arentsen-Honders MW, Kester MG, ter Riet PM, Willemze R. Increase in Ara-C sensitivity in Ara-C sensitive and -resistant leukemia by stimulation of the salvage and inhibition of the de novo pathway. Ann Hematol. 1992;65(1):26-32.
-
(1992)
Ann Hematol
, vol.65
, Issue.1
, pp. 26-32
-
-
Colly, L.P.1
Richel, D.J.2
Arentsen-Honders, M.W.3
Kester, M.G.4
Ter Riet, P.M.5
Willemze, R.6
-
40
-
-
27344445309
-
Electroporation by nucleofector is the best nonviral transfection technique in human endothelial and smooth muscle cells
-
Iversen N, Birkenes B, Torsdalen K, Djurovic S. Electroporation by nucleofector is the best nonviral transfection technique in human endothelial and smooth muscle cells. Genet Vaccines Therapy. 2005;3(1):2.
-
(2005)
Genet Vaccines Therapy
, vol.3
, Issue.1
, pp. 2
-
-
Iversen, N.1
Birkenes, B.2
Torsdalen, K.3
Djurovic, S.4
-
41
-
-
15044340106
-
Biochemical modulation of cytarabine triphosphate by clofarabine
-
Cooper T, Ayres M, Nowak B, Gandhi V. Biochemical modulation of cytarabine triphosphate by clofarabine. Cancer Chemother Pharmacol. 2005;55(4):361-8.
-
(2005)
Cancer Chemother Pharmacol
, vol.55
, Issue.4
, pp. 361-368
-
-
Cooper, T.1
Ayres, M.2
Nowak, B.3
Gandhi, V.4
-
42
-
-
0025020135
-
The effect of Ara-C-induced inhibition of DNA synthesis on its cellular pharmacology
-
Wang LM, White JC, Capizzi RL. The effect of Ara-C-induced inhibition of DNA synthesis on its cellular pharmacology. Cancer Chemother Pharmacol. 1990;25(6):418-24.
-
(1990)
Cancer Chemother Pharmacol
, vol.25
, Issue.6
, pp. 418-424
-
-
Wang, L.M.1
White, J.C.2
Capizzi, R.L.3
-
43
-
-
0036533498
-
Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line
-
Verschuur AC, Van Gennip AH, Leen R, Voute PA, Brinkman J, Van Kuilenburg AB. Cyclopentenyl cytosine increases the phosphorylation and incorporation into DNA of 1-beta-D-arabinofuranosyl cytosine in a human T-lymphoblastic cell line. Int J Cancer. 2002;98(4):616-23.
-
(2002)
Int J Cancer
, vol.98
, Issue.4
, pp. 616-623
-
-
Verschuur, A.C.1
Van Gennip, A.H.2
Leen, R.3
Voute, P.A.4
Brinkman, J.5
Van Kuilenburg, A.B.6
-
44
-
-
0017926507
-
Increased CTP synthetase activity in cancer cells
-
Williams JC, Kizaki H, Weber G, Morris HP. Increased CTP synthetase activity in cancer cells. Nature. 1978;271(5640):71-3.
-
(1978)
Nature
, vol.271
, Issue.5640
, pp. 71-73
-
-
Williams, J.C.1
Kizaki, H.2
Weber, G.3
Morris, H.P.4
-
45
-
-
2342467325
-
Problems related to resistance to cytarabine in acute myeloid leukemia
-
Cros E, Jordheim L, Dumontet C, Galmarini CM. Problems related to resistance to cytarabine in acute myeloid leukemia. Leuk Lymphoma. 2004;45(6):1123-32.
-
(2004)
Leuk Lymphoma
, vol.45
, Issue.6
, pp. 1123-1132
-
-
Cros, E.1
Jordheim, L.2
Dumontet, C.3
Galmarini, C.M.4
-
46
-
-
0021966123
-
Simultaneous determination of cytosine arabinoside, its nucleotides and metabolites by ion-pair high-performance liquid chromatography
-
Schilsky RL, Ordway FS. Simultaneous determination of cytosine arabinoside, its nucleotides and metabolites by ion-pair high-performance liquid chromatography. J Chromatogr. 1985;337(1):63-71.
-
(1985)
J Chromatogr
, vol.337
, Issue.1
, pp. 63-71
-
-
Schilsky, R.L.1
Ordway, F.S.2
-
47
-
-
0018906892
-
Quantitation of 1-beta-D-arabinofuranosylcytosine 5′-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy
-
Plunkett W, Hug V, Keating MJ, Chubb S. Quantitation of 1-beta-D-arabinofuranosylcytosine 5′-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D- arabinofuranosylcytosine therapy. Cancer Res. 1980;40(3):588-91.
-
(1980)
Cancer Res
, vol.40
, Issue.3
, pp. 588-591
-
-
Plunkett, W.1
Hug, V.2
Keating, M.J.3
Chubb, S.4
|